TradingView
warrenhochfeld
Nov 1, 2017 7:02 PM
Dynavax final breakout ahead of PDUFA Heplisav announcement
Long
NASDAQ:DVAX
15
Dynavax Technologies Corporation
NASDAQ
Description
⋅
Nov 1, 2017 7:02 PM
Start of final bull run ahead of 9th November FDA announcement of Heplisav . $28 price projection. Final buy opportunity at $20
Trend Analysis
Beyond Technical Analysis
More